TABLE 1.
Treatmenta | Level of transendothelial migration (cells/HPF) ofb:
|
|
---|---|---|
Neutrophils | Monocytes | |
Mock | 5.9 ± 0.6 | 2.9 ± 0.4 |
C. trachomatis L2 | ||
Live | 9.4 ± 1.7 | 7.0 ± 1.6* |
Heat inactivated | 8.0 ± 1.6 | 4.9 ± 0.9 |
UV inactivated | 12.0 ± 1.3 | 4.8 ± 0.6 |
C. pneumoniae TW-183 | ||
Live | 22.8 ± 3.2** | 12.9 ± 1.2*** |
Heat inactivated | 10.5 ± 1.1 | 4.7 ± 0.6 |
UV inactivated | 16.0 ± 1.1** | 6.2 ± 1.1 |
HUVEC monolayers cultured in transwells were inoculated with C. trachomatis L2 or C. pneumoniae TW-183 at a multiplicity of infection of 1:1. Equivalent inoculum concentrations of each strain were inactivated by heat or UV light before infection (see Materials and Methods). Mock-infected cells were treated with a suspension of lysed HEp-2 cells.
Levels of neutrophil and monocyte transendothelial migration were determined following 24 h of incubation as described in Materials and Methods. Data represent means ± standard errors of the means of three separate experiments. In each experiment, triplicate wells were assayed separately for each condition for neutrophil and monocyte migration. *, P < 0.05; **, P < 0.01; ***, P < 0.001.